Sign Up for Alerts
Sign up to receive receive industry-specific emails from our legal team.
Sign Up for Alerts
We provide tailored, industry-specific legal updates to our clients and other friends of the firm.
Areas of Interest
January 26th, 2026
Automated Content Recognition Technology Takes Privacy Enforcement Spotlight
The IAPP quotes Andrew Folks in its coverage of Texas’ lawsuits over automated content recognition technology. Folks views that the core issue is the gap between what consumers reasonably expect and what smart TVs actually collect. He explained that people may anticipate tracking within a streaming app but often do not realize manufacturers can monitor viewing through external devices like DVD players or HDMI inputs.
Folks also noted that onboarding practices have long undermined meaningful consent, with ACR permissions frequently bundled into device setup. He added that Texas’ actions show how states can use broad deceptive‑practices statutes to address opaque data‑collection technologies, saying such laws offer “clearer enforcement pathways and broader remedies” than comprehensive privacy frameworks. Read the full article on the lawsuit here.
Other Quoted
Climate Diaries Cannes Lions 2026
Jeffrey A. Greenbaum is featured in the 51toCarbonZero article, Climate Diaries Cannes Lions 2026, which features eleven interviews with senior leaders from across the media and advertising industry conducted at the Cannes Lions International Festival of Creativity. Read more.
August 5 2026
‘I have been hunted down by HR reps, lawyers, and comms people:’ Developers discuss the pain and prevalence of side work clauses
Wendy Stryker was quoted in a Game Developer article discussing "side work clauses," also known as "moonlighting clauses," in video game industry employment contracts. Read more.
July 30 2026
Experts: Ending Adequate Provision Would Shut Down Prescription Drug Ads
Jeffrey A. Greenbaum was quoted in the Regulatory Affairs Professionals Society (RAPS) article, "Experts: Ending Adequate Provision Would Shut Down Prescription Drug Ads." The article discusses the FDA's proposal to eliminate the "adequate provision" requirement in direct-to-consumer (DTC) prescription drug advertising, a change that experts say could effectively result in a de facto ban on prescription drug advertisements. Read more.
July 21 2026
